https://shark.law/productrisk/recall/openfda-drug-d-0857-2026-sterling-pharmaceutical-services-llc-walgreens-lubricant-eye-drops-carboxym-7735c7 2026-08-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0858-2026-sterling-pharmaceutical-services-llc-walgreens-lubricant-eye-drops-0-5-fl-o-170ffe 2026-08-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0814-2026-baxter-healthcare-corporation-nexterone-amiodarone-hci-360-mg-200-ml-1-8-mg-5e3517 2026-08-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0715-2026-rohto-mentholatum-vietnam-co-ltd-rohto-cooling-eye-drops-all-in-one-hyprome-0daddc 2026-07-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0716-2026-rohto-mentholatum-vietnam-co-ltd-rohto-cooling-eye-drops-max-strength-napha-4c80d7 2026-07-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0717-2026-rohto-mentholatum-vietnam-co-ltd-rohto-cooling-eye-drops-max-strength-napha-bf9672 2026-07-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0718-2026-rohto-mentholatum-vietnam-co-ltd-rohto-cooling-eye-drops-optic-glow-naphazo-6c7bd2 2026-07-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0722-2026-rohto-mentholatum-vietnam-co-ltd-rohto-cooling-eye-drops-cool-relief-naphaz-3ccbfb 2026-07-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0690-2026-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-1c83a8 2026-07-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0643-2026-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-1c66ca 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0645-2026-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-58be26 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0646-2026-carefusion-213-llc-chloraprep-frepp-clear-2-w-v-chlorhexidine-gluconate-chg-101d1f 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0647-2026-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-6858da 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0648-2026-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-33d9b5 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0649-2026-carefusion-213-llc-bd-chloraprep-scrub-teal-2-w-v-chlorhexidine-gluconate-c-04a931 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0651-2026-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-551050 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0663-2026-biomed-laboratories-llc-medline-remedy-specialized-silicone-cream-hydraguar-56070c 2026-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0583-2026-breckenridge-pharmaceutical-inc-duloxetine-delayed-release-capsules-usp-60m-adafab 2026-06-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0612-2026-amgen-inc-corlanor-ivabradine-tablets-5-mg-packaged-in-a-14-tablets-bottles-66422d 2026-06-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0655-2026-lupin-pharmaceuticals-inc-prednisolone-acetate-ophthalmic-suspension-usp-1--c83c25 2026-06-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0622-2026-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-b2ca45 2026-05-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0623-2026-carefusion-213-llc-bd-chloraprep-frepp-clear-2-w-v-chlorhexidine-gluconate--4d13a3 2026-05-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0546-2026-ucb-biosciences-inc-cimzia-certolizumab-pegol-2x200mg-ml-prefilled-syringes-14f180 2026-05-08 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0491-2026-alcon-research-llc-systane-lubricant-eye-gel-night-gel-sterile-10g-0-35-oz--3d2e2b 2026-04-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0490-2026-premier-dental-products-co-premier-monsel-s-ferric-subsulfate-solution-8-ml-74a485 2026-04-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0497-2026-b-braun-medical-inc-0-9-sodium-chloride-irrigation-usp-3000-ml-bags-rx-only-3b8d1e 2026-04-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0504-2026-wells-pharma-of-houston-llc-fentanyl-citrate-injectable-solution-in-0-9-sod-ee7dde 2026-04-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0419-2026-appco-pharma-llc-prazosin-hydrochloride-capsules-usp-1mg-100-count-bottle-r-a8d0c3 2026-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0421-2026-appco-pharma-llc-prazosin-hydrochloride-capsules-usp-5mg-100-count-bottle-r-2df7a2 2026-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0447-2026-ge-healthcare-ireland-limited-ge-healthcare-omnipaque-iohexol-injection-300-ba8d13 2026-03-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0448-2026-ge-healthcare-ireland-limited-ge-healthcare-omnipaque-iohexol-injection-350-320739 2026-03-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0406-2026-teva-pharmaceuticals-usa-inc-octreotide-acetate-for-injectable-suspension-f-02af03 2026-03-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0422-2026-cipla-usa-inc-lanreotide-injection-120-mg-0-5-ml-box-contains-1-pre-filled--f02fbd 2026-03-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0423-2026-cipla-usa-inc-lanreotide-injection-120-mg-0-5-ml-box-contains-1-pre-filled--d67fc7 2026-03-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0427-2026-fresenius-kabi-usa-llc-0-9-sodium-chloride-injection-usp-2-250-mg-per-250-m-3c8553 2026-03-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0430-2026-fresenius-kabi-usa-llc-0-9-sodium-chloride-injection-usp-900-mg-per-100-ml--012093 2026-03-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0433-2026-fresenius-kabi-usa-llc-0-9-sodium-chloride-injection-usp-900-mg-per-100-ml--e03f27 2026-03-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0409-2026-k-c-pharmaceuticals-inc-sterile-eye-drops-ac-tetrahydrozoline-hcl-0-05-zinc-f764f7 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0410-2026-k-c-pharmaceuticals-inc-eye-drops-advanced-relief-dextran-70-0-1-polyethyle-59e0e2 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0411-2026-k-c-pharmaceuticals-inc-dry-eye-relief-eye-drops-glycerin-0-2-hypromellose--2dbc74 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0412-2026-k-c-pharmaceuticals-inc-ultra-lubricating-eye-drops-polyethylene-400-0-4-pr-151cbc 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0413-2026-k-c-pharmaceuticals-inc-sterile-eye-drops-original-formula-tetrahydrozoline-0fbe7b 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0414-2026-k-c-pharmaceuticals-inc-sterile-eye-drops-redness-lubricant-glycerin-0-25-a-46973f 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0416-2026-k-c-pharmaceuticals-inc-artificial-tears-sterile-lubricant-eye-drops-polyvi-d3ba0e 2026-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0361-2026-acme-united-corporation-first-aid-only-bzk-antiseptic-towelette-benzalkoniu-7dd440 2026-01-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0366-2026-acme-united-corporation-med-nap-bzk-antiseptic-towelettes-benzalkonium-chlo-58ac4c 2026-01-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0353-2026-mckesson-udenyca-pegfilgrastim-cbqv-injection-6-mg-0-6ml-single-dose-prefil-dd79d1 2026-01-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0290-2026-cipla-usa-inc-lanreotide-injection-120-mg-0-5-ml-0-5-ml-per-pre-filled-syri-bbfcb1 2026-01-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0246-2026-glenmark-pharmaceuticals-inc-usa-ondansetron-orally-disintegrating-tablets--ccc2fa 2025-12-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0159-2026-zydus-pharmaceuticals-usa-inc-bromocriptine-mesylate-capsules-usp-5-mg-30-c-168b6b 2025-10-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0152-2026-zydus-pharmaceuticals-usa-inc-clomipramine-hydrochloride-capsules-usp-25-mg-13cf9d 2025-10-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0153-2026-zydus-pharmaceuticals-usa-inc-clomipramine-hydrochloride-capsules-usp-50-mg-51b32d 2025-10-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0154-2026-zydus-pharmaceuticals-usa-inc-clomipramine-hydrochloride-capsules-usp-75-mg-d7eabc 2025-10-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0158-2026-golden-state-medical-supply-inc-niacin-extended-release-tablets-usp-1-000-m-614dd2 2025-10-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0030-2026-the-harvard-drug-group-llc-gabapentin-capsules-usp-100-mg-100-capsules-10-x-3244d1 2025-10-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0031-2026-the-harvard-drug-group-llc-gabapentin-capsules-usp-100-mg-10-capsules-10-x--75db71 2025-10-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0029-2026-rising-pharma-holding-inc-carbidopa-levodopa-entacapone-tablets-25-mg-100-m-9f8d9a 2025-10-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0104-2026-teva-pharmaceuticals-usa-inc-prazosin-hydrochloride-capsules-usp-1-mg-rx-on-6db215 2025-10-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0105-2026-teva-pharmaceuticals-usa-inc-prazosin-hydrochloride-capsules-usp-2-mg-rx-on-d5cb78 2025-10-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0106-2026-teva-pharmaceuticals-usa-inc-prazosin-hydrochloride-capsules-usp-5-mg-rx-on-3c9d7b 2025-10-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0019-2026-ascend-laboratories-llc-atorvastatin-calcium-tablets-usp-20-mg-rx-only-a-90-b0fc9b 2025-09-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0020-2026-ascend-laboratories-llc-atorvastatin-calcium-tablets-usp-80-mg-rx-only-a-90-358ed3 2025-09-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0651-2025-sandoz-inc-cyclophosphamide-injection-500-mg-5-ml-100-mg-ml-hazardous-drug--5f11ec 2025-09-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0636-2025-zydus-pharmaceuticals-usa-inc-chlorpromazine-hydrochloride-tablets-usp-100--c60ff3 2025-09-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0638-2025-zydus-pharmaceuticals-usa-inc-chlorpromazine-hydrochloride-tablets-usp-200--a7b58b 2025-09-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0625-2025-the-harvard-drug-group-llc-dba-major-pharmaceuticals-and-rugby-laboratories-5bf01d 2025-09-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0647-2025-amerisource-health-services-llc-chlorpromazine-hydrochloride-tablets-usp-25-17800b 2025-08-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0654-2025-northwind-pharmaceuticals-llc-sulfamethoxazole-and-trimethoprim-tablets-usp-565885 2025-08-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0642-2025-lannett-company-inc-dextroamphetamine-saccharate-amphetamine-aspartate-dext-5ce9f5 2025-08-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0615-2025-amneal-pharmaceuticals-llc-sulfamethoxazole-and-trimethoprim-tablets-usp-80-3415c0 2025-08-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0617-2025-amneal-pharmaceuticals-llc-chlorpromazine-hydrochloride-tablets-usp-50-mg-1-e24544 2025-08-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0583-2025-glenmark-pharmaceuticals-inc-usa-theophylline-extended-release-tablets-400m-aa77d5 2025-08-08 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0534-2025-ascend-laboratories-llc-rizatriptan-benzoate-tablets-usp-10-mg-18-3x6-unit--c45f37 2025-07-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0532-2025-lupin-pharmaceuticals-inc-lisinopril-and-hydrochlorothiazide-tablets-usp-20-6ad378 2025-06-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0526-2025-orient-pharma-co-ltd-yunlin-plant-pitavastatin-tablets-2-mg-rx-only-90-tabl-bb0ebf 2025-06-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0490-2025-fresenius-medical-care-holdings-inc-0-9-sodium-chloride-injection-usp-flexi-b03ccc 2025-05-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0468-2025-ascend-laboratories-llc-cephalexin-for-oral-suspension-usp-125-mg-per-5-ml--e98b93 2025-05-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0469-2025-ascend-laboratories-llc-cephalexin-for-oral-suspension-usp-125-mg-per-5-ml--1b6869 2025-05-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0444-2025-asttrazeneca-pharmaceuticals-lp-airsupra-albuterol-and-budesonide-inhalatio-8663b3 2025-05-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0442-2025-zydus-pharmaceuticals-usa-inc-esomeprazole-magnesium-for-delayed-release-or-2e5def 2025-05-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0443-2025-zydus-pharmaceuticals-usa-inc-esomeprazole-magnesium-for-delayed-release-or-46305c 2025-05-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0401-2025-mckesson-medical-surgical-inc-corporate-office-infuvite-adult-multiple-vita-44e484 2025-04-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0404-2025-brs-analytical-services-llc-artificial-tears-ophthalmic-solution-dextran-70-5974bb 2025-04-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0406-2025-brs-analytical-services-llc-carboxymethylcellulose-sodium-ophthalmic-soluti-e1d667 2025-04-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0407-2025-brs-analytical-services-llc-lubricant-eye-drops-solution-polyethylene-glyco-943e25 2025-04-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0408-2025-brs-analytical-services-llc-polyvinyl-alcohol-ophthalmic-solution-1-4-lubri-9b55c0 2025-04-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0398-2025-american-regent-inc-nicardipine-hydrochloride-injection-usp-25-mg-10-ml-2-5-cff3c1 2025-04-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0320-2025-glenmark-pharmaceuticals-inc-usa-gabapentin-tablets-600mg-500-count-bottles-8c3cdf 2025-03-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0348-2025-glenmark-pharmaceuticals-inc-usa-cetirizine-hydrochloride-tablets-usp-10mg--553846 2025-03-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0293-2025-strides-pharma-inc-testosterone-gel-1-2-5-grams-30-unit-dose-packets-in-a-c-96e977 2025-03-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0294-2025-strides-pharma-inc-testosterone-gel-1-5-grams-30-unit-dose-packets-in-a-car-c817ed 2025-03-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0448-2025-glenmark-pharmaceuticals-inc-usa-carvedilol-tablets-usp-3-125mg-tablets-a-1-e25f8d 2025-02-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0449-2025-glenmark-pharmaceuticals-inc-usa-carvedilol-tablets-usp-6-25-mg-a-100-count-5d89f1 2025-02-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0285-2025-amgen-inc-neupogen-filgrastim-for-injection-300mcg-1-ml-1-ml-single-dose-vi-2e0073 2025-02-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0286-2025-amgen-inc-neupogen-filgrastim-for-injection-480-mcg-1-6-ml-300-mcg-1-ml-1-6-d59b71 2025-02-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0273-2025-denison-pharmaceuticals-llc-zapzyt-acne-treatment-gel-10-benzoyl-peroxide-g-bfa195 2025-02-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0255-2025-zydus-pharmaceuticals-usa-inc-nelarabine-injection-250mg-50ml-5mg-ml-packag-ee9293 2025-02-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0267-2025-icu-medical-inc-potassium-chloride-inj-20-meq-total-in-100-ml-flexible-cont-3fadad 2025-02-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0275-2025-johnson-s-c-and-son-inc-kids-by-babyganics-spf-50-totally-tropical-titanium-944e15 2025-02-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0276-2025-johnson-s-c-and-son-inc-kids-by-babyganics-spf-50-mineral-sunscreen-totally-774d67 2025-02-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0233-2025-glenmark-pharmaceuticals-inc-usa-atomoxetine-capsules-usp-25-mg-30-capsule--e5f564 2025-01-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0240-2025-glenmark-pharmaceuticals-inc-usa-atomoxetine-capsules-usp-25-mg-30-capsule--f34262 2025-01-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0215-2025-glenmark-pharmaceuticals-inc-usa-carvedilol-tablets-usp-25-mg-rx-only-a-500-2eef03 2025-01-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0216-2025-glenmark-pharmaceuticals-inc-usa-carvedilol-tablets-usp-12-5-mg-rx-only-a-5-fc223b 2025-01-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0226-2025-the-harvard-drug-group-llc-dba-major-pharmaceuticals-and-rugby-laboratories-6508ad 2025-01-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0227-2025-the-harvard-drug-group-llc-dba-major-pharmaceuticals-and-rugby-laboratories-d8a4e6 2025-01-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0228-2025-the-harvard-drug-group-llc-dba-major-pharmaceuticals-and-rugby-laboratories-ef5e2d 2025-01-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0125-2025-viatris-inc-levothyroxine-sodium-tablets-usp-75-mcg-packaged-in-a-90-count--59ec58 2024-11-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0127-2025-viatris-inc-levothyroxine-sodium-tablets-usp-100-mcg-packaged-in-a-90-count-04205f 2024-11-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0137-2025-keystone-industries-gelato-benzocaine-20-topical-gel-anesthetic-gel-net-wt--05713e 2024-11-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0141-2025-keystone-industries-patterson-dental-patterson-topical-anesthetic-gel-benzo-70a155 2024-11-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0142-2025-keystone-industries-health-tec-topical-anesthetic-gel-benzocaine-20-made-in-0e30d5 2024-11-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0145-2025-keystone-industries-safco-sensicaine-ultra-topical-anesthetic-gel-contains--308289 2024-11-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0052-2025-lupin-pharmaceuticals-inc-ramipril-capsules-usp-2-5-mg-a-90-count-ndc-68180-39e409 2024-10-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0053-2025-lupin-pharmaceuticals-inc-ramipril-capsules-usp-5-mg-a-90-count-ndc-68180-5-73ecb3 2024-10-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0054-2025-lupin-pharmaceuticals-inc-ramipril-capsules-usp-10-mg-a-90-count-ndc-68180--278790 2024-10-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0030-2025-accord-healthcare-inc-cinacalcet-tablets-30-mg-rx-only-a-30-tablets-per-bot-f3a11b 2024-10-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0026-2025-dr-reddy-s-laboratories-inc-cinacalcet-tablets-30-mg-30-count-bottle-rx-onl-6450f9 2024-10-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0013-2025-zhejiang-jingwei-pharmaceutical-co-ltd-first-aid-antiseptic-ointment-povido-7721cc 2024-09-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0668-2024-ascend-laboratories-llc-mycophenolic-acid-delayed-release-tablets-usp-360-m-49c6a2 2024-09-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0660-2024-glenmark-pharmaceuticals-inc-usa-mupirocin-ointment-usp-2-22-g-rx-only-manu-c525eb 2024-08-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0644-2024-dr-reddy-s-laboratories-inc-ibu-ibuprofen-tablets-usp-800-mg-rx-only-distri-101cd4 2024-08-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0645-2024-dr-reddy-s-laboratories-inc-ibu-ibuprofen-tablets-usp-600-mg-rx-only-distri-453418 2024-08-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0646-2024-dr-reddy-s-laboratories-inc-ibu-ibuprofen-tablets-usp-400-mg-rx-only-distri-59a96e 2024-08-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0612-2024-glenmark-pharmaceuticals-inc-usa-pravastatin-sodium-tablets-usp-80mg-packag-a7e30c 2024-06-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0619-2024-amerisource-health-services-llc-potassium-chloride-extended-release-capsule-40e14d 2024-06-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0604-2024-glenmark-pharmaceuticals-inc-usa-potassium-chloride-extended-release-capsul-9256d0 2024-05-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0605-2024-glenmark-pharmaceuticals-inc-usa-potassium-chloride-extended-release-capsul-ff24ca 2024-05-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0606-2024-glenmark-pharmaceuticals-inc-usa-potassium-chloride-extended-release-capsul-72afd4 2024-05-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0607-2024-glenmark-pharmaceuticals-inc-usa-potassium-chloride-extended-release-capsul-621cb1 2024-05-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0560-2024-consumer-product-partners-llc-petroleum-jelly-white-petrolatum-usp-net-wt-1-5b20af 2024-05-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0589-2024-synchronicity-spa-inc-dba-sunte-suntegrity-zinc-oxide-15-impeccable-skin-su-a2b144 2024-05-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0531-2024-regeneron-pharmaceuticals-inc-eylea-aflibercept-injection-for-intravitreal--7401c5 2024-05-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0539-2024-bryant-ranch-prepack-inc-cephalexin-for-oral-suspension-usp-250mg-per-5ml-r-48c2a4 2024-05-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0350-2024-sun-pharmaceutical-industries-inc-mesalamine-extended-release-capsules-usp--9bb1e5 2024-02-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0150-2024-sun-pharmaceutical-industries-inc-liothyronine-sodium-tablets-usp-5-mcg-100-431566 2023-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0146-2024-baxter-healthcare-corporation-ondansetron-injection-usp-4-mg-2-ml-2-mg-ml-2-8729bd 2023-11-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0128-2024-golden-state-medical-supply-inc-paroxetine-tablets-usp-10-mg-packaged-as-a--d4f063 2023-11-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0129-2024-golden-state-medical-supply-inc-paroxetine-tablets-usp-20-mg-packaged-as-a--7c87a9 2023-11-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0130-2024-golden-state-medical-supply-inc-paroxetine-tablets-usp-40-mg-packaged-as-a--6b6afe 2023-11-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0082-2024-safecor-health-llc-strong-iodine-solution-u-s-p-lugol-s-solution-iodine-5-1-4fe9db 2023-10-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0097-2024-zydus-pharmaceuticals-usa-inc-oxybutynin-chloride-extended-release-tablet-u-1c6085 2023-10-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1148-2023-be-pharmaceuticals-ag-pantoprazole-sodium-for-injection-40mg-per-vial-singl-2d4416 2023-09-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1168-2023-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-6e1992 2023-08-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1140-2023-baxter-healthcare-corporation-dianeal-low-calcium-2-5-meq-l-peritoneal-dial-19f41f 2023-08-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1145-2023-ascend-laboratories-llc-fosfomycin-tromethamine-granules-for-oral-solution--4f69aa 2023-07-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0897-2023-k-c-pharmaceuticals-inc-original-eye-drops-redness-reliever-tetrahydrozolin-5d2d94 2023-06-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0898-2023-k-c-pharmaceuticals-inc-dry-eye-relief-lubricant-eye-drops-glycerin-0-2-hyp-ffff66 2023-06-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0765-2023-aurobindo-pharma-usa-inc-pain-reliever-acetaminophen-usp-caplets-500-mg-225-506c47 2023-05-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0668-2023-central-admixture-pharmacy-services-inc-cardioplegia-solution-del-nido-form-679fa9 2023-04-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0556-2023-bryant-ranch-prepack-inc-lidocaine-patch-5-1-patch-63629-8755-20-packaged-i-df6804 2023-04-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0475-2023-endo-pharmaceuticals-inc-calcitonin-salmon-nasal-spray-usp-2200-internation-491d65 2023-03-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0433-2023-apotex-corp-brimonidine-tartrate-ophthalmic-solution-0-15-rx-only-packaged--bc65b9 2023-03-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0346-2023-b-braun-medical-inc-0-9-sodium-chloride-injection-usp-1000-ml-excel-plus-co-f4e7bd 2023-02-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0347-2023-b-braun-medical-inc-0-9-sodium-chloride-injection-usp-500-ml-excel-plus-con-c7c5e1 2023-02-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0905-2023-l-perrigo-company-allergy-aller-fex-fexofenadine-hydrochloride-tablets-180--019adb 2023-02-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0365-2023-accord-healthcare-inc-aripiprazole-tablets-usp-2-mg-rx-only-packaged-as-a-3-642640 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0366-2023-accord-healthcare-inc-aripiprazole-tablets-usp-5-mg-rx-only-packaged-as-a-3-0d4308 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0367-2023-accord-healthcare-inc-aripiprazole-tablets-usp-10-mg-rx-only-packaged-as-a--d119f3 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0368-2023-accord-healthcare-inc-aripiprazole-tablets-usp-15-mg-rx-only-packaged-as-a--94b090 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0369-2023-accord-healthcare-inc-aripiprazole-tablets-usp-20-mg-rx-only-packaged-as-a--0762d7 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0370-2023-accord-healthcare-inc-aripiprazole-tablets-usp-30-mg-rx-only-a-30-count-bot-f94d8e 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0371-2023-accord-healthcare-inc-atorvastatin-calcium-tablets-usp-10-mg-rx-only-packag-08d305 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0372-2023-accord-healthcare-inc-atorvastatin-calcium-tablets-usp-20-mg-rx-only-packag-1973d7 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0373-2023-accord-healthcare-inc-atorvastatin-calcium-tablets-usp-40-mg-rx-only-packag-b329dc 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0374-2023-accord-healthcare-inc-atorvastatin-calcium-tablets-usp-80-mg-rx-only-packag-48d731 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0381-2023-accord-healthcare-inc-daptomycin-for-injection-350-mg-vial-rx-only-packaged-c64056 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0382-2023-accord-healthcare-inc-daptomycin-for-injection-500-mg-per-vial-single-dose--b8112d 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0383-2023-accord-healthcare-inc-dofetilide-capsules-125-mcg-0-125-mg-60-count-bottle--0fc09d 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0384-2023-accord-healthcare-inc-dofetilide-capsules-250-mcg-0-25-mg-60-count-bottle-r-31e611 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0385-2023-accord-healthcare-inc-dofetilide-capsules-500-mcg-0-5-mg-60-count-bottle-rx-eb826a 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0388-2023-accord-healthcare-inc-doxazosin-tablets-usp-4-mg-rx-only-packaged-as-a-100--93e542 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0392-2023-accord-healthcare-inc-finasteride-tablets-usp-5-mg-rx-only-packaged-as-a-30-b112a1 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0393-2023-accord-healthcare-inc-glimepiride-tablets-usp-1-mg-rx-only-packaged-in-a-10-5cc2b2 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0394-2023-accord-healthcare-inc-glimepiride-tablets-usp-2-mg-rx-only-packaged-in-a-10-a235ff 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0395-2023-accord-healthcare-inc-glimepiride-tablets-usp-4-mg-rx-only-packaged-in-a-10-1661bf 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0400-2023-accord-healthcare-inc-montelukast-sodium-tablets-usp-10-mg-rx-only-packaged-75ae5c 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0404-2023-accord-healthcare-inc-rosuvastatin-tablets-usp-5-mg-rx-only-packaged-as-a-9-6307a2 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0405-2023-accord-healthcare-inc-rosuvastatin-tablets-usp-10-mg-rx-only-packaged-as-a--b564fc 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0406-2023-accord-healthcare-inc-rosuvastatin-tablets-usp-20-mg-rx-only-packaged-as-a--e4cb03 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0407-2023-accord-healthcare-inc-rosuvastatin-tablets-usp-40-mg-rx-only-packaged-as-a--829166 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0408-2023-accord-healthcare-inc-simvastatin-tablets-usp-5-mg-rx-only-packaged-as-a-90-d304b2 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0409-2023-accord-healthcare-inc-simvastatin-tablets-usp-10-mg-rx-only-packaged-as-a-9-c20191 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0410-2023-accord-healthcare-inc-simvastatin-tablets-usp-20-mg-rx-only-packaged-as-a-9-023489 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0411-2023-accord-healthcare-inc-simvastatin-tablets-usp-40-mg-rx-only-packaged-as-a-9-3d1245 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0412-2023-accord-healthcare-inc-simvastatin-tablets-usp-80-mg-rx-only-packaged-as-a-9-6fe905 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0414-2023-accord-healthcare-inc-tadalafil-tablets-usp-2-5-mg-rx-only-packaged-as-a-30-88dbeb 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0415-2023-accord-healthcare-inc-tadalafil-tablets-usp-5-mg-rx-only-packaged-as-a-30-c-c2ca2e 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0416-2023-accord-healthcare-inc-tadalafil-tablets-usp-10-mg-rx-only-packaged-as-a-30--3440c5 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0417-2023-accord-healthcare-inc-tadalafil-tablets-usp-20-mg-rx-only-packaged-as-a-30--de3624 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0425-2023-accord-healthcare-inc-ropinirole-tablets-usp-0-25-mg-100-count-bottle-rx-on-90accb 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0426-2023-accord-healthcare-inc-ropinirole-tablets-usp-0-5-mg-100-count-bottle-rx-onl-dc572d 2023-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0262-2023-sun-pharmaceutical-industries-inc-diltiazem-hydrochloride-extended-release--b7d01f 2023-01-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0167-2023-intersect-ent-inc-sinuva-mometasone-furoate-sinus-implant-1350-mcg-1-implan-6dc966 2023-01-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0079-2023-exela-pharma-sciences-llc-8-4-sodium-bicarbonate-injection-usp-50-meq-50-ml-a407ce 2022-11-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0025-2023-genentech-inc-susvimo-ranibizumab-injection-100mg-ml-sold-together-as-a-car-c3d1f5 2022-10-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0015-2023-fresenius-medical-care-holdings-inc-0-9-sodium-chloride-injection-usp-each--5f4058 2022-10-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0022-2023-exela-pharma-sciences-llc-8-4-sodium-bicarbonate-injection-usp-50-meq-50-ml-eb0482 2022-10-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1550-2022-cipla-arformoterol-tartrate-inhalation-solution-15-mcg-2ml-2-ml-sterile-uni-ca9251 2022-09-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1499-2022-cipla-difluprednate-ophthalmic-emulsion-0-05-5-ml-bottle-rx-only-manufactur-7ba9ab 2022-08-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1348-2022-baxter-healthcare-corporation-acetaminophen-injection-10-mg-ml-1-000-mg-100-9f7a13 2022-08-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1304-2022-glenmark-pharmaceuticals-inc-usa-tacrolimus-ointment-0-1-for-dermatological-dd9c4c 2022-07-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1282-2022-glenmark-pharmaceuticals-inc-usa-aspirin-and-extended-release-dipyridamole--38b723 2022-06-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1244-2022-vi-jon-llc-hydrogen-peroxide-topical-solution-usp-3-16-fl-oz-1-pt-473-ml-bo-db425b 2022-06-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1173-2022-glenmark-pharmaceuticals-inc-usa-mometasone-furoate-topical-solution-usp-0--724d89 2022-06-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1151-2022-vi-jon-llc-70-isopropyl-alcohol-first-aid-antiseptic-4-fl-oz-118-ml-bottle--bd508e 2022-06-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1162-2022-pd-rx-pharmaceuticals-inc-losartan-potassium-tablets-usp-50-mg-90-tablets-b-c37a66 2022-06-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1163-2022-pd-rx-pharmaceuticals-inc-losartan-potassium-tablets-usp-100-mg-90-tablets--e313f5 2022-06-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0972-2022-strides-pharma-inc-losartan-potassium-tablets-usp-25-mg-rx-only-manufacture-849672 2022-05-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0973-2022-strides-pharma-inc-losartan-potassium-tablets-usp-50-mg-rx-only-manufacture-c13dd7 2022-05-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0974-2022-strides-pharma-inc-losartan-potassium-tablets-usp-100-mg-rx-only-manufactur-17b0fc 2022-05-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0982-2022-novartis-pharmaceuticals-corporation-xiidra-lifitegrast-ophthalmic-solution-7af04b 2022-05-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0857-2022-sun-pharmaceutical-industries-inc-bupropion-hydrochloride-extended-release--bb0ba8 2022-04-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0993-2022-mckesson-medical-surgical-inc-corporate-office-epi-pen-2-pak-epinephrine-in-00d1aa 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0994-2022-mckesson-medical-surgical-inc-corporate-office-miocol-e-acetylcholine-chlor-8c4744 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0995-2022-mckesson-medical-surgical-inc-corporate-office-tobradex-tobramycin-and-dexa-119609 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0997-2022-mckesson-medical-surgical-inc-corporate-office-azithromycin-for-injection-u-485529 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0998-2022-mckesson-medical-surgical-inc-corporate-office-bupivacaine-hcl-injection-si-4c8c1e 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1008-2022-mckesson-medical-surgical-inc-corporate-office-betadine-5-sterile-ophthalmi-74d5cd 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1009-2022-mckesson-medical-surgical-inc-corporate-office-ampicillin-for-injection-usp-b952c7 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1012-2022-mckesson-medical-surgical-inc-corporate-office-epi-pen-jr-2-pak-epinephrine-d62968 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1013-2022-mckesson-medical-surgical-inc-corporate-office-epinephrine-injection-usp-si-4df281 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1014-2022-mckesson-medical-surgical-inc-corporate-office-epinephrine-injection-usp-si-9fc173 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1018-2022-mckesson-medical-surgical-inc-corporate-office-albuterol-sulfate-inhalation-5bc55f 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1019-2022-mckesson-medical-surgical-inc-corporate-office-albuterol-sulfate-inhalation-c38567 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1020-2022-mckesson-medical-surgical-inc-corporate-office-albuterol-sulfate-inhalation-bbf23b 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1021-2022-mckesson-medical-surgical-inc-corporate-office-ipratropium-bromide-0-5-mg-a-833aba 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1022-2022-mckesson-medical-surgical-inc-corporate-office-adrenalin-epinephrine-inject-58a9a0 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1024-2022-mckesson-medical-surgical-inc-corporate-office-albuterol-sulfate-inhalation-e583ed 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1025-2022-mckesson-medical-surgical-inc-corporate-office-amoxicillin-capsules-usp-500-e120a3 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1026-2022-mckesson-medical-surgical-inc-corporate-office-aparaclonidine-ophthalmic-so-7ffbd2 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1027-2022-mckesson-medical-surgical-inc-corporate-office-aprepitant-capsule-usp-40-mg-47fd06 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1031-2022-mckesson-medical-surgical-inc-corporate-office-sterile-water-for-injection--b4944f 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1032-2022-mckesson-medical-surgical-inc-corporate-office-doxycycline-capsules-usp-100-5b6983 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1033-2022-mckesson-medical-surgical-inc-corporate-office-bss-sterile-irrigating-solut-4a7400 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1034-2022-mckesson-medical-surgical-inc-corporate-office-bss-sterile-irrigating-solut-a49791 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1035-2022-mckesson-medical-surgical-inc-corporate-office-isopto-atropine-atropine-sul-b11397 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1036-2022-mckesson-medical-surgical-inc-corporate-office-miostat-carbachol-intraocula-23b313 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1037-2022-mckesson-medical-surgical-inc-corporate-office-meclizine-hydrochloride-tabl-454f61 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1039-2022-mckesson-medical-surgical-inc-corporate-office-naltrexone-hydrochloride-tab-be8052 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1040-2022-mckesson-medical-surgical-inc-corporate-office-ipratropium-bromide-inhalati-0ebd74 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1043-2022-mckesson-medical-surgical-inc-corporate-office-lidocaine-patch-5-30-count-c-174e35 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1044-2022-mckesson-medical-surgical-inc-corporate-office-ciprofloxacin-ophthalmic-sol-767ed5 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1045-2022-mckesson-medical-surgical-inc-corporate-office-hydrocortisone-ointment-usp--937b10 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1046-2022-mckesson-medical-surgical-inc-corporate-office-hydroxyzine-pamoate-capsules-24b510 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1047-2022-mckesson-medical-surgical-inc-corporate-office-lidocaine-and-prilocaine-cre-ea2c08 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1052-2022-mckesson-medical-surgical-inc-corporate-office-xylocaine-epinephrine-multi--e3b98d 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1053-2022-mckesson-medical-surgical-inc-corporate-office-xylocaine-epinephrine-multi--415934 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1054-2022-mckesson-medical-surgical-inc-corporate-office-doxycycline-hyclate-tablets--6f39d8 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1055-2022-mckesson-medical-surgical-inc-corporate-office-ibuprofen-tablets-usp-400-mg-31af2b 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1058-2022-mckesson-medical-surgical-inc-corporate-office-sodium-bicarbonate-tablets-6-8964ec 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1059-2022-mckesson-medical-surgical-inc-corporate-office-sulfamethoxazole-and-trimeth-5600e1 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1065-2022-mckesson-medical-surgical-inc-corporate-office-ketoconazole-cream-2-net-wt--321907 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1067-2022-mckesson-medical-surgical-inc-corporate-office-levalbuterol-tartrate-hfa-in-7a16ed 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1068-2022-mckesson-medical-surgical-inc-corporate-office-lidocaine-patch-5-30-count-b-c374c2 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1075-2022-mckesson-medical-surgical-inc-corporate-office-mupirocin-ointment-usp-2-22--b1f010 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1081-2022-mckesson-medical-surgical-inc-corporate-office-revonto-dantrolene-sodium-fo-86b9e2 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1082-2022-mckesson-medical-surgical-inc-corporate-office-recothrom-thrombin-topical-r-5c9a84 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1083-2022-mckesson-medical-surgical-inc-corporate-office-transderm-scop-scopolamine-t-aa98e6 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1084-2022-mckesson-medical-surgical-inc-corporate-office-e-z-hd-barium-sulfate-for-or-7704dd 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1085-2022-mckesson-medical-surgical-inc-corporate-office-e-z-gas-ii-effervescent-gran-b8f98d 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1086-2022-mckesson-medical-surgical-inc-corporate-office-gastrografin-diatrizoate-meg-75710b 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1087-2022-mckesson-medical-surgical-inc-corporate-office-kinevac-sincalide-for-inject-f4a003 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1088-2022-mckesson-medical-surgical-inc-corporate-office-levofloxacin-tablets-500-mg--55d1d4 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1091-2022-mckesson-medical-surgical-inc-corporate-office-duraclon-clonidine-hcl-injec-891ead 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1092-2022-mckesson-medical-surgical-inc-corporate-office-loperamide-hydrochloride-cap-55cbcc 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1093-2022-mckesson-medical-surgical-inc-corporate-office-prazosin-hydrochloride-capsu-88e50f 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1095-2022-mckesson-medical-surgical-inc-corporate-office-bupivacaine-hydrochloride-us-2be2ef 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1096-2022-mckesson-medical-surgical-inc-corporate-office-depo-medrol-methylprednisolo-190c6c 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1097-2022-mckesson-medical-surgical-inc-corporate-office-depo-medrol-methylprednisolo-497f3d 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1101-2022-mckesson-medical-surgical-inc-corporate-office-diphenhydramine-hcl-oral-sol-ae8b41 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1102-2022-mckesson-medical-surgical-inc-corporate-office-neomycin-and-polymyxin-b-sul-dc748e 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1103-2022-mckesson-medical-surgical-inc-corporate-office-ondansetron-hcl-tab-8-mg-fil-7973ae 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1105-2022-mckesson-medical-surgical-inc-corporate-office-prednisolone-acetate-ophthal-581fcd 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1106-2022-mckesson-medical-surgical-inc-corporate-office-triamcinolone-acetonide-crea-80c02c 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1111-2022-mckesson-medical-surgical-inc-corporate-office-sumatriptan-succinate-tablet-e5c10e 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1112-2022-mckesson-medical-surgical-inc-corporate-office-geodon-for-injection-ziprasi-90de39 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1113-2022-mckesson-medical-surgical-inc-corporate-office-tetracaine-hydrochloride-oph-9202b5 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1114-2022-mckesson-medical-surgical-inc-corporate-office-ofloxacin-otic-solution-0-3--aab1fc 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1115-2022-mckesson-medical-surgical-inc-corporate-office-diprivan-propofol-emulsion-1-2911ea 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1116-2022-mckesson-medical-surgical-inc-corporate-office-diprivan-propofol-emulsion-2-e7282d 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1117-2022-mckesson-medical-surgical-inc-corporate-office-cefazolin-for-injection-usp--076af4 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1118-2022-mckesson-medical-surgical-inc-corporate-office-cefazolin-for-injection-usp--16382f 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1119-2022-mckesson-medical-surgical-inc-corporate-office-intralipid-i-v-fat-emulsion--f14c2a 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1120-2022-mckesson-medical-surgical-inc-corporate-office-intralipid-i-v-fat-emulsion--0521a8 2022-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0838-2022-lupin-pharmaceuticals-inc-losartan-potassium-tablets-usp-25-mg-a-90-count-b-ed6525 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0839-2022-lupin-pharmaceuticals-inc-losartan-potassium-tablets-usp-50-mg-a-90-count-b-96b6ae 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0840-2022-lupin-pharmaceuticals-inc-losartan-potassium-tablets-usp-100-mg-a-90-count--488112 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0841-2022-lupin-pharmaceuticals-inc-losartan-potassium-and-hydrochlorothiazide-tablet-76fdc0 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0842-2022-lupin-pharmaceuticals-inc-losartan-potassium-and-hydrochlorothiazide-tablet-46813c 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0843-2022-lupin-pharmaceuticals-inc-losartan-potassium-and-hydrochlorothiazide-tablet-3177f6 2022-03-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0747-2022-advanced-accelerator-applications-usa-inc-netspot-kit-for-the-preparation-o-1a51b7 2022-03-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1177-2022-golden-state-medical-supply-inc-enalapril-maleate-tablets-usp-2-5-mg-90-tab-1ca618 2022-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1178-2022-golden-state-medical-supply-inc-enalapril-maleate-tablets-usp-5-mg-90-table-ef0851 2022-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1179-2022-golden-state-medical-supply-inc-enalapril-maleate-tablets-usp-10-mg-90-tabl-a1e81a 2022-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0742-2022-vitae-enim-vitae-scientific-inc-papaverine-hydrochloride-injection-usp-60-m-9f0c00 2022-03-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0743-2022-vitae-enim-vitae-scientific-inc-phenobarbital-sodium-injection-usp-65mg-ml--5f629e 2022-03-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0744-2022-vitae-enim-vitae-scientific-inc-phenobarbital-sodium-injection-usp-130-mg-m-a38c7e 2022-03-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0767-2022-jubilant-cadista-pharmaceuticals-inc-meclizine-hydrochloride-tablets-usp-12-a0d8f4 2022-03-08 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0573-2022-rising-pharmaceuticals-methylphenidate-hydrochloride-chewable-tablets-2-5-m-c389f8 2022-02-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0570-2022-professional-disposables-international-inc-prevantics-chlorhexidine-glucona-92d6fb 2022-02-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0571-2022-professional-disposables-international-inc-prevantics-chlorhexidine-glucona-95d264 2022-02-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0572-2022-professional-disposables-international-inc-prevantics-chlorhexidine-glucona-e37322 2022-02-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0575-2022-dr-reddy-s-laboratories-inc-azacitidine-1-00mg-vial-one-single-dose-vial-rx-a6f6f6 2022-01-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0392-2022-viona-pharmaceuticals-inc-metformin-hydrochloride-extended-release-tablets--739dc8 2021-12-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0242-2024-the-procter-gamble-company-secret-powder-fresh-aluminum-chlorohydrate-24-an-acfe07 2021-11-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0253-2024-the-procter-gamble-company-secret-powder-fresh-aluminum-chlorohydrate-24-an-5b4f96 2021-11-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0159-2024-blistex-inc-odor-eaters-spray-powder-tolnaftate-1-antifungal-packaged-in-a--12d5ea 2021-11-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0227-2022-golden-state-medical-supply-inc-ezetimibe-and-simvastatin-tablets-10-mg-40m-589a48 2021-10-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0086-2022-lupin-pharmaceuticals-inc-irbesartan-tablets-usp-75-mg-a-30-count-ndc-68180-4a16cb 2021-10-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0087-2022-lupin-pharmaceuticals-inc-irbesartan-tablets-usp-150-mg-a-30-count-ndc-6818-803b0b 2021-10-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0088-2022-lupin-pharmaceuticals-inc-irbesartan-tablets-usp-300-mg-a-30-count-ndc-6818-8d853e 2021-10-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0240-2022-bayer-healthcare-pharmaceuticals-inc-lotrimin-af-tolnaftate-1-daily-prevent-9baa75 2021-10-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0243-2022-bayer-healthcare-pharmaceuticals-inc-tinactin-tolnaftate-1-liquid-spray-net-b48c63 2021-10-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0254-2022-bayer-healthcare-pharmaceuticals-inc-lotrimin-af-tolnaftate-1-daily-prevent-171115 2021-10-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0799-2021-vi-jon-inc-kroger-70-isopropyl-alcohol-first-aid-antiseptic-32-fl-oz-1-qt-9-7558e1 2021-09-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0820-2021-glenmark-pharmaceuticals-inc-usa-fulvestrant-injection-250-mg-5-ml-50-mg-ml-4b1b5f 2021-08-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0822-2021-glenmark-pharmaceuticals-inc-usa-naproxen-sodium-tablets-usp-550-mg-rx-only-a02e3a 2021-08-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0826-2021-glenmark-pharmaceuticals-inc-usa-zonisamide-capsules-usp-100-mg-rx-only-man-1c0b9d 2021-08-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0828-2021-avrio-health-l-p-betadine-solution-swabstick-povidone-iodine-solution-usp-1-4b03f2 2021-08-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0810-2021-pfizer-inc-chantix-varenicline-tablets-1-mg-56-tablets-rx-only-distributed--9b6277 2021-08-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0728-2021-dupont-nutrition-usa-inc-avicel-mirocrystalline-cellulose-packaged-in-bulk--f9743e 2021-08-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0758-2021-professional-disposables-international-inc-pdi-povidone-iodine-prep-pad-med-ffc0cc 2021-07-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0760-2021-professional-disposables-international-inc-pdi-povidine-iodine-swabstick-1--f699b6 2021-07-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0761-2021-professional-disposables-international-inc-pdi-povidone-iodine-swabstick-3--1986c5 2021-07-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0700-2021-pfizer-inc-chantix-varenicline-tablets-contains-1-starting-week-0-5-mg-x-11-1dd3fa 2021-06-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0637-2021-hill-dermaceuticals-inc-dermotic-oil-fluocinolone-acetonide-oil-0-01-ear-dr-9edf67 2021-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0626-2021-pfizer-inc-0-5-bupivacaine-hydrochloride-injection-usp-150-mg-30-ml-5-mg-ml-c3ee92 2021-05-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0627-2021-pfizer-inc-1-lidocaine-hcl-injection-usp-300-mg-30-ml-10-mg-ml-30-ml-single-176039 2021-05-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0373-2021-carefusion-213-llc-bd-chloraprep-hi-lite-orange-26-ml-applicator-2-w-v-chlo-64f864 2021-04-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0618-2021-novo-nordisk-inc-saxenda-liraglutide-injection-18-mg-3-ml-6-mg-ml-1-x-3-ml--2c0cac 2021-03-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0619-2021-novo-nordisk-inc-tresiba-flextouch-insulin-degludec-injection-100-units-ml--a4c72c 2021-03-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0621-2021-novo-nordisk-inc-tresiba-flextouch-insulin-degludec-injection-200-units-ml--c7fcf6 2021-03-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0343-2021-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-a40f25 2021-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0344-2021-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-b0e4ea 2021-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0347-2021-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-5fff3f 2021-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0348-2021-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-b6653d 2021-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0318-2021-ferring-pharmaceuticals-inc-zoma-jet-10-demonstration-kit-needle-free-deliv-c42ac6 2021-03-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0788-2021-china-gel-inc-china-gel-camphor-3-00-menthol-5-00-a-topical-pain-reliever-p-8d228c 2021-03-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0789-2021-china-gel-inc-china-gel-white-camphor-3-00-menthol-5-00-a-topical-pain-reli-334ac6 2021-03-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0790-2021-china-gel-inc-aulief-organic-camphor-3-00-organic-menthol-5-00-topical-pain-191ea1 2021-03-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0299-2021-ferring-pharmaceuticals-inc-menopur-75-iu-menotropins-for-injection-package-8a0b75 2021-03-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0358-2021-a-s-medication-solutions-llc-acetaminophen-extra-strength-aspirin-free-500--1cfd51 2021-03-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0291-2021-dr-reddy-s-laboratories-inc-atorvastatin-calcium-tablets-40mg-packaged-in-a-0abcba 2021-02-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0277-2021-teva-pharmaceuticals-usa-metoclopramide-injection-usp-10-mg-2-ml-5-mg-ml-2--be026d 2021-02-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0231-2021-genus-lifesciences-inc-oxycodone-hydrochloride-oral-solution-usp-5-mg-5ml-u-5b89fc 2020-12-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0176-2021-merck-sharp-dohme-zerbaxa-ceftolozane-and-tazobactam-1-5g-per-vial-for-inje-b9bd5d 2020-12-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0187-2021-sca-pharmaceuticals-buffered-lidocaine-hcl-1-5-ml-10mg-ml-with-sodium-bicar-d48948 2020-12-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0151-2021-taro-pharmaceuticals-u-s-a-inc-equate-athlete-s-foot-clotrimazole-usp-1-ant-94a7df 2020-11-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0069-2021-teva-pharmaceuticals-usa-mesalamine-delayed-release-tablets-usp-1-2-gram-12-1608aa 2020-10-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0059-2021-pd-rx-pharmaceuticals-inc-metformin-hcl-er-500-mg-a-30-tablets-ndc-72789-00-b6debc 2020-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0060-2021-pd-rx-pharmaceuticals-inc-metformin-hcl-er-750-mg-rx-only-pkg-by-pd-rx-phar-b3c4d4 2020-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0061-2021-marksans-pharma-limited-time-cap-labs-inc-metformin-hydrochloride-extended--aea65e 2020-10-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0062-2021-marksans-pharma-limited-time-cap-labs-inc-metformin-hydrochloride-extended--c8ca93 2020-10-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1594-2020-perrigo-company-plc-albuterol-sulfate-inhalation-aerosol-90-mcg-per-actuati-21f5b9 2020-09-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0012-2021-teva-pharmaceuticals-usa-cephalexin-for-oral-suspension-usp-125-mg-per-5-ml-3cd059 2020-08-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0013-2021-teva-pharmaceuticals-usa-cephalexin-for-oral-suspension-usp-250-mg-per-5-ml-950b39 2020-08-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1541-2020-the-mentholatum-company-red-cross-oral-pain-oral-anesthetic-benzocaine-20-m-470960 2020-07-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1391-2020-fresenius-kabi-usa-llc-fosaprepitant-for-injection-150-mg-vial-in-a-10-ml-s-79f285 2020-07-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1389-2020-keryx-biopharmaceuticals-inc-auryxia-ferric-citrate-tablets-210-mg-rx-only--496443 2020-07-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0265-2021-carefusion-213-llc-bd-chloraprep-clear-2-w-v-chlorhexidine-gluconate-chg-an-c57324 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0268-2021-carefusion-213-llc-bd-chloraprep-hi-lite-orange-2-w-v-chlorhexidine-glucona-16b427 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1382-2020-lupin-pharmaceuticals-inc-metformin-hydrochloride-extended-release-tablets--82970f 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1383-2020-lupin-pharmaceuticals-inc-metformin-hydrochloride-extended-release-tablets--e830e9 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1384-2020-lupin-pharmaceuticals-inc-metformin-hydrochloride-extended-release-tablets--cdd94a 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1385-2020-lupin-pharmaceuticals-inc-metformin-hydrochloride-extended-release-tablets--47c0e3 2020-07-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1386-2020-granules-pharmaceuticals-inc-metformin-hydrochloride-extended-release-table-49b6ab 2020-07-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1509-2020-carefusion-213-llc-bd-chloraprep-clear-3-ml-applicators-2-w-v-chlorhexidine-4f1640 2020-06-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1333-2020-pd-rx-pharmaceuticals-inc-metformin-hcl-er-500-mg-a-30-tablets-ndc-72789-00-1e3995 2020-06-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1373-2020-somerset-therapeutics-llc-brimonidine-tartrate-opthalmic-solution-0-2-5-ml--b64e71 2020-06-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1344-2020-amneal-pharmaceuticals-of-new-york-llc-amneal-metformin-hydrochloride-exten-3375ed 2020-05-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1345-2020-amneal-pharmaceuticals-of-new-york-llc-amneal-metformin-hydrochloride-exten-13a5c7 2020-05-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1347-2020-amneal-pharmaceuticals-of-new-york-llc-amneal-metformin-hydrochloride-exten-3830c9 2020-05-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1349-2020-amneal-pharmaceuticals-of-new-york-llc-amneal-metformin-hydrochloride-exten-d436ae 2020-05-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1325-2020-glaxosmithkline-consumer-healthcare-holdings-gaviscon-liquid-antacid-extra--3cc8d9 2020-05-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1276-2020-pd-rx-pharmaceuticals-inc-doxycycline-hyclate-tablets-usp-100-mg-packaged-i-194bb9 2020-05-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1065-2020-glaxosmithkline-consumer-healthcare-holdings-ibuprofen-200-mg-chlorpheniram-b661d6 2020-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1066-2020-glaxosmithkline-consumer-healthcare-holdings-ibuprofen-200-mg-liquid-filled-54b1cf 2020-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1067-2020-glaxosmithkline-consumer-healthcare-holdings-ibuprofen-50-mg-per-1-25-ml-or-616bb1 2020-03-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1033-2020-sun-pharmaceutical-industries-inc-doxycycline-capsules-usp-100-mg-50-count--34fa9a 2020-03-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1260-2020-teva-pharmaceuticals-usa-epinephrine-injection-usp-0-3-mg-auto-injector-0-3-d82a7f 2020-03-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0995-2020-pfizer-inc-elelyso-taliglucerase-alfa-for-injection-200-units-vials-rx-only-619c5d 2020-02-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0787-2020-sun-pharmaceutical-industries-inc-testosterone-cypionate-for-injection-usp--dd7ba3 2020-01-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0788-2020-sun-pharmaceutical-industries-inc-testosterone-cypionate-for-injection-2-00-879d2f 2020-01-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0615-2020-amneal-pharmaceuticals-inc-ranitidine-tablets-usp-150-mg-1000-count-bottles-eea2cd 2019-11-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0616-2020-amneal-pharmaceuticals-inc-ranitidine-tablets-usp-300-mg-250-count-bottles--ff32d9 2019-11-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0618-2020-glenmark-pharmaceuticals-inc-usa-clobetasol-propionate-foam-0-05-a-50-g-pac-d13bd0 2019-11-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0161-2020-sandoz-inc-bimatoprost-ophthalmic-solution-0-03-rx-only-for-topical-applica-43e69f 2019-10-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0162-2020-sandoz-inc-neomycin-and-polymyxin-b-sulfates-and-dexamethasone-ophthalmic-s-7e1104 2019-10-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0167-2020-arbor-pharmaceuticals-inc-testosterone-cypionate-injection-usp-2000-mg-10-m-04d052 2019-09-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0299-2020-taro-pharmaceuticals-u-s-a-inc-ibuprofen-oral-suspension-usp-100-mg-5-ml-on-02a1fd 2019-09-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1586-2019-glenmark-pharmaceuticals-inc-usa-mometasone-furoate-cream-usp-0-1-packaged--93dbaa 2019-07-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1508-2019-deva-holding-as-cerkezkoy-subesi-temozolomide-capsules-5-mg-packaged-in-a-5-bfebc0 2019-07-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1509-2019-deva-holding-as-cerkezkoy-subesi-temozolomide-capsules-20-mg-packaged-in-a--9aa997 2019-07-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1510-2019-deva-holding-as-cerkezkoy-subesi-temozolomide-capsules-100-mg-packaged-in-a-04a617 2019-07-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1511-2019-deva-holding-as-cerkezkoy-subesi-temozolomide-capsules-140-mg-packaged-in-a-7aadd8 2019-07-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1512-2019-deva-holding-as-cerkezkoy-subesi-temozolomide-capsules-180-mg-packaged-in-a-46aabe 2019-07-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0422-2020-altaire-pharmaceuticals-inc-altaire-fluorescein-sodium-with-proparacaine-hy-a82247 2019-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1459-2019-macleods-pharma-usa-inc-losartan-potassium-and-hydrochlorothiazide-tablets--e9b187 2019-06-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1461-2019-macleods-pharma-usa-inc-losartan-potassium-andhydrochlorothiazide-tablets-1-26aaaa 2019-06-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1395-2019-novis-pr-inc-pecgen-dmx-cough-suppressant-expectorant-contains-the-same-act-1af655 2019-05-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1294-2019-mallinckrodt-pharmaceuticals-amitiza-lubiprostone-capsules-8-mcg-60-count-b-3dd223 2019-05-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1295-2019-mallinckrodt-pharmaceuticals-amitiza-lubiprostone-capsules-24-mcg-60-count--88dc67 2019-05-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1467-2019-american-health-packaging-anastrozole-tablets-usp-1-mg-a-30-count-ndc-68001-84aa21 2019-05-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1440-2019-zydus-pharmaceuticals-usa-inc-anastrozole-tablets-1-mg-rx-only-30-count-bot-ec1ee6 2019-05-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1449-2019-zydus-pharmaceuticals-usa-inc-methylprednisolone-tablets-usp-4-mg-per-table-2d9522 2019-05-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1307-2019-septodont-inc-articaine-dental-articane-hydrochloride-4-and-epinephrine-1-1-147b8b 2019-05-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1121-2019-lupin-pharmaceuticals-inc-telmisartan-and-amlodipine-tablets-80-mg-5-mg-30--c53850 2019-04-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1123-2019-invagen-pharmaceuticals-inc-testosterone-cypionate-injection-usp-2000-mg-10-a7fd55 2019-03-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1124-2019-invagen-pharmaceuticals-inc-testosterone-cypionate-injection-usp-200-mg-ml--4189d6 2019-03-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0341-2021-pd-rx-pharmaceuticals-inc-losartan-potassium-usp-50-mg-rx-only-pkg-by-pd-rx-09b7a4 2019-03-08 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1041-2019-camber-pharmaceuticals-inc-losartan-potassium-tablets-usp-25-mg-rx-only-a-9-8db720 2019-02-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1042-2019-camber-pharmaceuticals-inc-losartan-potassium-tablets-usp-50-mg-rx-only-a-3-4ba62a 2019-02-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1043-2019-camber-pharmaceuticals-inc-losartan-potassium-tablets-usp-100-mg-rx-only-a--3fa21a 2019-02-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0517-2019-lupin-pharmaceuticals-inc-moxifloxacin-ophthalmic-solution-usp-0-5-3-ml-bot-194d53 2019-02-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0484-2019-lupin-pharmaceuticals-inc-moxifloxacin-ophthalmic-solution-usp-0-5-3-ml-dro-7af813 2019-02-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0390-2019-lupin-somerset-fluocinolone-acetonide-topical-solution-usp-0-01-60-ml-bottl-55d5ce 2019-01-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0423-2019-lupin-pharmaceuticals-inc-cephalexin-for-oral-suspension-usp-250mg-5-ml-rx--8d5c3e 2019-01-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0375-2019-lupin-pharmaceuticals-inc-cefdinir-for-oral-suspension-usp-125mg-5ml-packag-c54464 2019-01-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0376-2019-lupin-pharmaceuticals-inc-cefdinir-for-oral-suspension-usp-250mg-5ml-packag-b7a5ea 2019-01-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0361-2019-aurobindo-pharma-usa-inc-amlodipine-and-valsartan-tablets-usp-5-mg-160-mg-3-59d5c7 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0362-2019-aurobindo-pharma-usa-inc-amlodipine-and-valsartan-tablets-usp-10-mg-160-mg--3dc33e 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0363-2019-aurobindo-pharma-usa-inc-amlodipine-and-valsartan-tablets-usp-5-mg-320-mg-3-faa17f 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0364-2019-aurobindo-pharma-usa-inc-amlodipine-and-valsartan-tablets-usp-10-mg-320-mg--97b9cf 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0365-2019-aurobindo-pharma-usa-inc-valsartan-and-hydrochlorothiazide-tablets-usp-320m-f49945 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0366-2019-aurobindo-pharma-usa-inc-valsartan-and-hydrochlorothiazide-tablets-usp-160m-44f3fd 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0367-2019-aurobindo-pharma-usa-inc-valsartan-and-hydrochlorothiazide-tablets-usp-320--ba4d04 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0368-2019-aurobindo-pharma-usa-inc-valsartan-and-hydrochlorothiazide-tablets-usp-80-m-eb85cb 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0369-2019-aurobindo-pharma-usa-inc-valsartan-and-hydrochlorothiazide-tablets-usp-160--224495 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0370-2019-aurobindo-pharma-usa-inc-valsartan-tablets-usp-320-mg-90-count-bottles-rx-o-ddc1d7 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1035-2019-aurobindo-pharma-usa-inc-valsartan-tablets-usp-320-mg-90-count-bottles-rx-o-26e0e8 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1037-2019-aurobindo-pharma-usa-inc-valsartan-tablets-usp-40-mg-30-count-bottles-rx-on-5045fc 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1039-2019-aurobindo-pharma-usa-inc-valsartan-tablets-usp-160-mg-90-count-bottles-rx-o-2acde4 2018-12-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0350-2019-glenmark-pharmaceuticals-inc-usa-estradiol-vaginal-inserts-usp-10-mcg-rx-on-958467 2018-12-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0346-2019-lupin-somerset-nitrofurantoin-oral-suspension-usp-25mg-5ml-230-ml-bottle-rx-d4a87e 2018-12-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0387-2019-allergan-plc-ozurdex-dexamethasone-intravitreal-implant-0-7-mg-1-single-use-865c1d 2018-12-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0294-2019-dr-reddy-s-laboratories-inc-clopidogrel-tablets-usp-300-mg-30-5-x-6-unit-do-2b2afd 2018-12-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0320-2019-mylan-laboratories-limited-nashik-fdf-amlodipine-and-valsartan-tablets-usp--d9832d 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0322-2019-mylan-laboratories-limited-nashik-fdf-amlodipine-and-valsartan-tablets-usp--358752 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0323-2019-mylan-laboratories-limited-nashik-fdf-amlodipine-and-valsartan-tablets-usp--67ff02 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0325-2019-mylan-laboratories-limited-nashik-fdf-valsartan-tablets-usp-80-mg-90-count--58ba0d 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0326-2019-mylan-laboratories-limited-nashik-fdf-valsartan-tablets-usp-160-mg-90-count-9f4a33 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0327-2019-mylan-laboratories-limited-nashik-fdf-valsartan-tablets-usp-320-mg-90-count-a8a61c 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0328-2019-mylan-laboratories-limited-nashik-fdf-valsartan-and-hydrochlorothiazide-tab-2b6bbc 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0329-2019-mylan-laboratories-limited-nashik-fdf-valsartan-and-hydrochlorothiazide-tab-340082 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0332-2019-mylan-laboratories-limited-nashik-fdf-valsartan-and-hydrochlorothiazide-tab-839762 2018-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0298-2019-fresenius-kabi-usa-llc-sodium-chloride-injection-usp-0-9-10-ml-single-dose--8dca8b 2018-11-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0299-2019-fresenius-kabi-usa-llc-sodium-chloride-injection-usp-0-9-20-ml-single-dose--7b1875 2018-11-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0485-2019-dr-reddy-s-laboratories-inc-levetiracetam-in-0-54-sodium-chloride-injection-ef6fd6 2018-10-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0222-2019-baxter-healthcare-corporation-metoprolol-tartrate-injection-usp-5-mg-5-ml-1-c96df3 2018-10-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1215-2018-baxter-healthcare-corporation-levofloxacin-injection-in-5-dextrose-5-mg-ml--01b267 2018-09-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0005-2019-pfizer-inc-elelyso-taliglucerase-alfa-for-injection-200-units-vial-single-u-62448c 2018-09-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0103-2019-dr-reddy-s-laboratories-inc-zoledronic-acid-injection-5mg-100-ml-0-05-mg-ml-7f8708 2018-09-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1207-2018-noven-pharmaceuticals-inc-minivelle-estradiol-transdermal-system-patches-de-94e6f5 2018-09-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1212-2018-invagen-pharmaceuticals-inc-bupropion-hydrochloride-er-tablets-usp-150-mg-p-65290f 2018-09-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0002-2019-biolyte-laboratories-llc-neorelief-for-muscle-cramping-restlessness-homeopa-795ff9 2018-08-31 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1188-2018-united-therapeutics-corp-tyvaso-inhalation-system-patient-a-starter-kit-wit-6bf769 2018-08-14 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1127-2018-pd-rx-pharmaceuticals-inc-doxycycline-hyclate-usp-tablets-100-mg-packaged-i-535bc4 2018-08-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1036-2018-baxter-healthcare-corporation-levofloxacin-injection-in-5-dextrose-750-mg-5-1db89e 2018-08-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0818-2018-sun-pharmaceutical-industries-inc-riomet-metformin-hydrochloride-oral-solut-08d40c 2018-04-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0703-2018-auromedics-pharma-llc-linezolid-injection-600-mg-per-300-ml-2-mg-ml-for-int-7ccc99 2018-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0705-2018-auromedics-pharma-llc-levetiracetam-in-0-82-sodium-chloride-injection-500-m-5eb37d 2018-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0706-2018-auromedics-pharma-llc-levetiracetam-in-0-75-sodium-chloride-injection-1000--caf327 2018-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0708-2018-auromedics-pharma-llc-levofloxacin-in-5-dextrose-injection-500-mg-levofloxa-a8e32d 2018-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0709-2018-auromedics-pharma-llc-levofloxacin-in-5-dextrose-injection-750-mg-levofloxa-ad7791 2018-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0606-2018-glenmark-pharmaceuticals-inc-usa-indomethacin-capsules-usp-50-mg-100-count--86d0de 2018-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0620-2018-teva-pharmaceuticals-usa-estradiol-vaginal-inserts-usp-10-mcg-packaged-in-a-3a5f0c 2018-03-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0250-2018-g-w-laboratories-inc-ciclopirox-olamine-cream-usp-0-77-packaged-in-a-15-g-t-e251cb 2018-01-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0685-2018-time-cap-laboratories-inc-ibuprofen-tablets-usp-200-mg-a-50-tablets-ndc-494-e149be 2018-01-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0689-2018-time-cap-laboratories-inc-ibuprofen-tablets-usp-600-mg-a-100-tablet-ndc-494-d81fc9 2018-01-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0692-2018-time-cap-laboratories-inc-ibuprofen-tablets-usp-800-mg-a-100-tablet-ndc-494-1e9b59 2018-01-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0237-2018-marksans-pharma-inc-ibuprofen-tablets-usp-200-mg-6-x-6500-tablets-bulk-pack-a09ecb 2018-01-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0009-2018-dr-reddy-s-laboratories-inc-famotidine-tablets-10-mg-packaged-in-30-count-b-02a40e 2017-10-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0030-2018-baxter-healthcare-corporation-intralipid-20-a-20-i-v-fat-emulsion-100-ml-ba-b698b1 2017-09-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1118-2017-pd-rx-pharmaceuticals-inc-phentermine-capsules-15-mg-a-7-count-bottle-ndc-5-2a700b 2017-08-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0120-2018-amneal-pharmaceuticals-of-new-york-llc-lorazepam-oral-concentrate-usp-2-mg--2e7e86 2017-08-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1083-2017-kvk-tech-inc-phentermine-hcl-capsules-usp-15-mg-packaged-in-a-100-count-bot-9d5b04 2017-08-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0945-2017-g-w-laboratories-inc-g-w-clobetasol-propionate-ointment-0-05-packaged-in-a--c0ed39 2017-06-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0884-2017-dr-reddy-s-laboratories-inc-zenatane-isotretinoin-capsules-usp-20-mg-30-cou-9cec9f 2017-05-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0885-2017-dr-reddy-s-laboratories-inc-zenatane-isotretinoin-capsules-usp-30-mg-30-cou-069b3f 2017-05-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0886-2017-dr-reddy-s-laboratories-inc-zenatane-isotretinoin-capsules-usp-40-mg-30-cou-7d9ce0 2017-05-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0698-2017-par-sterile-products-llc-buprenorphine-hci-injection-0-3-mg-ml-1-ml-single--feded1 2017-04-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0676-2017-taro-pharmaceuticals-u-s-a-inc-nystatin-and-triamcinolone-acetonide-cream-u-f106f0 2017-03-28 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0636-2017-g-w-laboratories-inc-ciclopirox-olamine-cream-usp-0-77-packaged-in-a-15-g-t-ae9bb4 2017-03-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0690-2017-meridian-medical-technologies-a-pfizer-company-epipen-2-pak-epinephrine-aut-7a29ee 2017-03-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0691-2017-meridian-medical-technologies-a-pfizer-company-epipen-jr-2-pak-epinephrine--c4dfb5 2017-03-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0510-2017-leo-pharma-inc-calcipotriene-cream-0-0005-packaged-in-a-60g-tube-ndc-66993--446f2a 2017-01-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0465-2017-vistapharm-inc-methadone-hydrochloride-oral-concentrate-usp-10-mg-ml-c-ii-a-7d46ff 2017-01-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0477-2017-leo-pharma-inc-taclonex-calcipotriene-and-betamethasone-dipropionate-topica-0e5134 2017-01-16 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0495-2017-abbvie-inc-duopa-carbidopa-and-levodopa-enteral-suspension-4-63-mg-20-mg-pe-3530f4 2017-01-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0445-2017-sun-pharmaceutical-industries-inc-bupropion-hydrochloride-extended-release--563210 2016-12-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0229-2017-sage-products-llc-comfort-shield-dimethicone-barrier-cream-cloths-3-package-7496a8 2016-07-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0230-2017-sage-products-llc-comfort-shield-dimethicone-barrier-cream-cloths-3-package-1e428c 2016-07-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0231-2017-sage-products-llc-2-chlorhexidine-gluconate-cloth-2-disposable-cloths-per-p-4c3913 2016-07-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1460-2016-zydus-pharmaceuticals-usa-inc-venlafaxine-hcl-er-capsule-usp-150mg-packaged-2984d0 2016-07-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1502-2016-lupin-pharmaceuticals-inc-lisinopril-tablets-usp-30-mg-packaged-in-a-500-co-8ed341 2016-04-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1503-2016-lupin-pharmaceuticals-inc-lisinopril-tablets-usp-40-mg-1000-count-bottles-r-4bd515 2016-04-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1493-2016-lupin-limited-amlodipine-besylate-tablets-usp-10mg-1000-count-bottles-rx-on-884ab8 2016-02-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0645-2016-bausch-lomb-inc-cyclopentolate-hydrochloride-ophthalmic-solution-usp-1-pack-fefd44 2016-01-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0646-2016-bausch-lomb-inc-tropicamide-ophthalmic-solution-usp-0-5-packaged-in-15-ml-b-bee9a4 2016-01-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0647-2016-bausch-lomb-inc-tropicamide-ophthalmic-solution-usp-1-packaged-in-a-2-ml-bo-2feffb 2016-01-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0775-2016-virtus-pharmaceuticals-llc-virt-nate-prenatal-postnatal-prescription-folate-79136f 2016-01-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0719-2016-dr-reddy-s-laboratories-inc-paricalcitol-capsules-1-mcg-30-capsules-per-bot-9537b1 2015-11-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1817-2015-allergan-sales-llc-refresh-lacri-lube-mineral-oil-42-5-and-white-petrolatum-e08ec8 2015-08-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1818-2015-allergan-sales-llc-refresh-p-m-mineral-oil-42-5-and-white-petrolatum-57-3-l-77e737 2015-08-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0574-2016-pd-rx-pharmaceuticals-inc-phentermine-hydrochloride-capsules-usp-15-mg-pack-82b5c8 2015-07-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1318-2015-glaxosmithkline-consmer-healthcare-biotene-gentle-formula-fluoride-toothpas-4ea869 2015-07-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1323-2015-glaxosmithkline-consmer-healthcare-sensodyne-extra-fresh-repair-protect-3-4-0fedd0 2015-07-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1324-2015-glaxosmithkline-consmer-healthcare-sensodyne-with-fluoride-repair-protect-a-1a179c 2015-07-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1241-2015-hospira-inc-ketorolac-tromethamine-inj-usp-30-mg-30-mg-ml-1-ml-fill-single--509215 2015-06-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1242-2015-hospira-inc-ketorolac-tromethamine-inj-usp-60-mg-30-mg-ml-2-ml-fill-single--654944 2015-06-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1363-2015-reckitt-benckiser-llc-mucinex-fast-max-cold-flu-sore-throat-maximum-strengt-f469ec 2015-04-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1369-2015-reckitt-benckiser-llc-mucinex-fast-max-dm-max-maximum-strength-dextromethor-b3d4b9 2015-04-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0961-2015-nomax-inc-fluorescein-sodium-ophthalmic-strips-usp-0-6-mg-per-strip-labeled-5505a0 2015-03-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0962-2015-nomax-inc-rose-bengal-glostrips-rose-bengal-ophthalmic-strips-usp-1-3-mg-pe-3d93a4 2015-03-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0423-2015-matheson-inc-air-compressed-medical-air-usp-rx-only-matheson-tri-gas-inc-15-be087a 2015-03-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0482-2015-hospira-inc-ketorolac-tromethamine-inj-usp-30-mg-30-mg-ml-1-ml-fill-single--700cd2 2015-01-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0483-2015-hospira-inc-ketorolac-tromethamine-inj-usp-60-mg-30-mg-ml-2-ml-fill-single--48d6cb 2015-01-23 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0320-2015-k-c-pharmaceuticals-inc-eye-drops-tetrahydrozoline-hcl-0-05-0-5-fl-oz-15-ml-746664 2014-12-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0433-2015-hospira-inc-mitoxantrone-injection-usp-concentrate-2-mg-ml-rx-only-hospira--a34fe0 2014-12-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0234-2015-obagi-medical-products-obagi-nu-derm-clear-am-pm-3-skin-bleaching-and-corre-fbec30 2014-10-17 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0387-2015-hospira-inc-vancomycin-hydrochloride-for-injection-usp-500-mg-sterile-powde-ccfae6 2014-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0388-2015-hospira-inc-ketorolac-tromethamine-inj-usp-60-mg-30-mg-ml-2-ml-single-dose--d37637 2014-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0389-2015-hospira-inc-propofol-injectable-emulsion-1-200-mg-20-ml-10-mg-ml-20-ml-sing-8846bb 2014-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0390-2015-hospira-inc-vancomycin-hydrochloride-for-injection-usp-1-g-sterile-powder-p-51f16a 2014-10-06 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1558-2014-perrigo-holland-inc-nicotine-polacrilex-lozenge-2-mg-mint-mini-27-ct-tubes--7a4122 2014-08-19 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-0019-2015-valeant-pharmaceuticals-north-america-llc-vasotec-enalapril-maleate-tablets-3ce96c 2014-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1428-2014-fresenius-kabi-usa-llc-fosphenytoin-sodium-injection-usp-100-mg-pe-2-ml-50--50dfba 2014-05-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1429-2014-fresenius-kabi-usa-llc-fosphenytoin-sodium-injection-usp-500-mg-pe-10-ml-50-057a08 2014-05-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1352-2014-prestige-brands-holdings-pediacare-brand-nighttime-multi-symptom-cold-diphe-dbccde 2014-04-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1353-2014-prestige-brands-holdings-pediacare-brand-day-night-value-pack-daytime-multi-b33552 2014-04-25 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1344-2014-sigmapharm-laboratories-llc-liothyronine-sodium-tablets-usp-5-mcg-rx-only-a-ccfebd 2014-04-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1410-2014-bausch-lomb-inc-muro-128-sodium-chloride-hypertonicity-ophthalmic-ointment--a3fb52 2014-04-10 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1547-2014-hospira-inc-propofol-injectable-emulsion-1-200-mg-20-ml-10-mg-ml-for-i-v-ad-745582 2014-04-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1230-2014-boehringer-ingelheim-roxane-inc-spiriva-handihaler-tiotropium-bromide-inhal-3eb45e 2014-03-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1576-2014-apotex-inc-paroxetine-hcl-controlled-release-tablets-25-mg-30-count-bottle--e67983 2014-03-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1227-2014-novartis-pharmaceuticals-corp-ritalin-hcl-methylphenidate-hcl-usp-10-mg-100-98c10b 2014-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1228-2014-novartis-pharmaceuticals-corp-ritalin-hcl-methylphenidate-hcl-usp-20-mg-100-7ad53d 2014-03-03 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1240-2014-glaxosmithkline-consumer-healthcare-dba-glaxosmithkline-nicotine-polacrilex-854a1b 2014-02-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1241-2014-glaxosmithkline-consumer-healthcare-dba-glaxosmithkline-nicotine-polacrilex-ad3cb3 2014-02-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1245-2014-glaxosmithkline-consumer-healthcare-dba-glaxosmithkline-nicorette-nicotine--a79967 2014-02-20 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1280-2014-teva-pharmaceuticals-usa-fluoxetine-capsules-usp-20-mg-packaged-in-a-100-co-b116a5 2014-02-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-745-2014-pfizer-inc-zithromax-azithromycin-for-injection-500-mg-vial-sterile-rx-only--dfe3d7 2014-01-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1033-2014-hospira-inc-propofol-injectible-emulsion-1-200-mg-20-ml-10-mg-ml-20-ml-sing-93b3dc 2013-12-12 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1031-2014-kvk-tech-inc-hydroxyzine-hci-tablets-usp-25-mg-100-500-and-1000-count-bottl-9cb343 2013-12-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1032-2014-kvk-tech-inc-hydroxyzine-hci-tablets-usp-50-mg-100-500-and-1000-count-bottl-92947c 2013-12-11 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1076-2014-faria-limited-llc-dba-sheffield-pharmaceuticals-dr-sheffield-triple-antibio-bca0cc 2013-11-22 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1162-2014-baxter-healthcare-corp-5-dextrose-injection-usp-100-ml-single-dose-viaflex--ef8565 2013-11-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1163-2014-baxter-healthcare-corp-0-9-sodium-chloride-injection-usp-packaged-in-a-50-m-05ad4b 2013-11-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-016-2014-fresenius-kabi-usa-llc-paclitaxel-injection-usp-semisynthetic-300-mg-50-ml-6-3819c7 2013-11-08 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-66462-001-nephron-pharmaceuticals-corp-albuterol-sulfate-inhalation-solution-0-083-2--bd34ec 2013-10-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1057-2013-boehringer-ingelheim-roxane-inc-spiriva-handihaler-tiotropium-bromide-inhal-7f44b7 2013-08-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1018-2014-aidapak-services-llc-ascorbic-acid-tablet-250-mg-over-the-counter-distribut-7c34de 2013-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-910-2014-aidapak-services-llc-fluvastatin-capsule-20-mg-rx-only-distributed-by-aidapa-a6feee 2013-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-933-2014-aidapak-services-llc-cyanocobalamin-tablet-1000-mcg-over-the-counter-distrib-1aaf8b 2013-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-985-2014-aidapak-services-llc-methylprednisolone-tablet-4-mg-rx-only-distributed-by-a-3a547c 2013-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-752-2014-novartis-consumer-health-theraflu-multi-symptom-severe-cold-acetaminophen-50-65b830 2013-06-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-609-2013-pharmacia-upjohn-llc-cleocin-phosphate-clindamycin-injection-usp-a-600-mg-4m-76b986 2013-06-04 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-624-2013-baxter-healthcare-corp-0-9-sodium-chloride-injection-usp-in-mini-bag-plus-co-ca6dce 2013-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-625-2013-baxter-healthcare-corp-5-dextrose-injection-usp-in-viaflex-plastic-container-196283 2013-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-626-2013-baxter-healthcare-corp-heparin-sodium-and-0-9-sodium-chloride-injection-a-pr-b1a9e3 2013-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-628-2013-baxter-healthcare-corp-sodium-chloride-injection-usp-a-product-code-2b1301-5-ad0799 2013-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-629-2013-baxter-healthcare-corp-metronidazole-injection-usp-rtu-500-mg-100ml-in-viafl-73e0cf 2013-05-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-929-2013-beamonstar-products-sexvoltz-all-natural-herbal-supplement-packaged-in-1-2-c-319609 2013-05-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-930-2013-beamonstar-products-velextra-all-natural-herbal-supplement-packaged-in-1-2-c-2029c6 2013-05-01 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1223-2014-american-lifestyle-com-vicerex-a-powerful-and-fast-acting-male-sexual-enhan-921922 2013-04-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1224-2014-american-lifestyle-com-black-ant-4600-mg-x-4-product-is-packaged-in-a-small-6b7ed7 2013-04-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-422-2013-king-legacy-a-wholly-owned-subsidiary-of-pfizer-levoxyl-levothyroxine-sodium-078ff8 2013-04-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-423-2013-king-legacy-a-wholly-owned-subsidiary-of-pfizer-levoxyl-levothyroxine-sodium-6e73cf 2013-04-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-425-2013-king-legacy-a-wholly-owned-subsidiary-of-pfizer-levoxyl-levothyroxine-sodium-235987 2013-04-30 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-598-2013-teva-pharmaceuticals-usa-inc-amoxicillin-for-oral-suspension-usp-400mg-5ml-n-b36f0d 2013-04-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-268-2013-sandoz-incorporated-amoxicillin-capsules-usp-500-mg-manufactured-in-austria--a329cc 2013-04-18 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-329-2013-glenmark-generics-inc-usa-glenmark-gabapentin-tablets-a-600mg-500-count-bott-0d71e2 2013-04-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-330-2013-glenmark-generics-inc-usa-glenmark-pravastatin-sodium-tablets-40-mg-90-count-c7e2af 2013-04-05 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-681-2013-teva-pharmaceuticals-usa-inc-lessina-r-levonorgestrel-and-ethinyl-estradiol--79d3a5 2013-03-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-682-2013-teva-pharmaceuticals-usa-inc-junel-tm-fe-1-5-30-norethindrone-acetate-and-et-aa572a 2013-03-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-209-2013-novartis-consumer-health-4-way-nasal-decongestant-fast-acting-nasal-spray-co-f4b06c 2013-03-07 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-086-2013-taro-pharmaceuticals-u-s-a-inc-fluorouracil-topical-cream-usp-5-40-g-tube-rx-ba2d82 2012-11-21 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-159-2013-hospira-inc-propofol-injectable-emulsion-1-packaged-in-a-20-ml-single-patien-7245ce 2012-11-15 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-072-2013-ranbaxy-inc-atorvastatin-calcium-tablets-40-mg-a-90-tablets-per-bottle-b-500-4139c4 2012-11-09 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-064-2013-glaxosmithkline-llc-advair-hfa-fluticasone-propionate-45-mcg-and-salmeterol--28a884 2012-10-24 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1685-2012-hospira-inc-propofol-injectable-emulsion-1-packaged-in-a-20-ml-single-patie-dc5132 2012-08-29 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1666-2012-glaxosmithkline-inc-ventolin-hfa-albuterol-sulfate-inhalation-aerosol-90-mc-41fdc4 2012-07-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1648-2012-hospira-inc-carboplatin-injection-10-mg-ml-a-5-ml-multi-dose-vials-ndc-6170-eadf70 2012-07-02 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1679-2012-hospira-inc-carboplatin-injection-10-mg-ml-45-ml-multi-dose-vial-rx-only-an-cb02ce 2012-06-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1680-2012-hospira-inc-cytarabine-injection-20-mg-ml-50-ml-single-dose-vial-rx-only-an-344635 2012-06-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1681-2012-hospira-inc-methotrexate-injection-usp-25-mg-ml-40-ml-single-dose-vial-rx-o-31389e 2012-06-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1682-2012-hospira-inc-paclitaxel-injection-6-mg-ml-50-ml-single-dose-vial-rx-only-ant-f687af 2012-06-27 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1423-2012-bayer-healthcare-llc-midol-complete-acetaminophen-caffeine-pyrilamine-malea-a9fbda 2012-04-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1424-2012-bayer-healthcare-llc-midol-complete-acetaminophen-caffeine-pyrilamine-malea-32489b 2012-04-26 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1437-2012-west-ward-pharmaceutical-corp-fosphenytoin-sodium-injection-usp-100-mg-pe-p-36d79b 2012-04-13 monthly 0.5 https://shark.law/productrisk/recall/openfda-drug-d-1438-2012-west-ward-pharmaceutical-corp-fosphenytoin-sodium-injection-usp-500-mg-pe-p-e8e35a 2012-04-13 monthly 0.5